𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Genetic profiling and epidermal growth factor receptor-directed therapy in nonsmall cell lung cancer

✍ Scribed by Cadranel, J.; Zalcman, G.; Sequist, L.

Book ID
111652392
Publisher
European Respiratory Society
Year
2010
Tongue
English
Weight
949 KB
Volume
37
Category
Article
ISSN
0903-1936

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Epidermal growth factor ligand/receptor
Epidermal growth factor ligand/receptor loop and downstream signaling activation pattern in completely resected nonsmall cell lung cancer
✍ Marco Volante; Silvia Saviozzi; Ida Rapa; Paolo Ceppi; Susanna Cappia; Raffaele πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 396 KB

## Abstract ## BACKGROUND. In recent years, molecular insights shed light on the role of the epidermal growth factor receptor (EGFR) in nonsmall cell lung cancer (NSCLC), and new therapeutic agents, such as the EGFR tyrosine kinase inhibitors, were tested successfully, with responsiveness to those

Epidermal growth factor receptor mutatio
Epidermal growth factor receptor mutations detected by denaturing high-performance liquid chromatography in nonsmall cell lung cancer : Impact on response to therapy with epidermal growth factor receptor-tyrosine kinase inhibitors
✍ Victor Cohen; Jason S. Agulnik; Celina Ang; Goulnar Kasymjanova; Gerald Batist; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Somatic mutations in the epidermal growth factor receptor (EGFR) kinase domain are associated with sensitivity to EGFR‐tyrosine kinase inhibitors (EGFR‐TKI) in patients with nonsmall cell lung cancer (NSCLC). ## METHODS: The authors tested the possibility that nucleoti